nach oben

Erschienen in:

01.08.2014 | Magnetic Resonance Imaging

Recurrent glioblastoma multiforme versus radiation injury: a multiparametric 3-T MR approach

verfasst von: Alfonso Di Costanzo, Tommaso Scarabino, Francesca Trojsi, Teresa Popolizio, Simona Bonavita, Mario de Cristofaro, Renata Conforti, Adriana Cristofano, Claudio Colonnese, Ugo Salvolini, Gioacchino Tedeschi

Erschienen in: La radiologia medica | Ausgabe 8/2014

Einloggen, um Zugang zu erhalten

Abstract

Objective

The discrimination between recurrent glioma and radiation injury is often a challenge on conventional magnetic resonance imaging (MRI). We verified whether adding and combining proton MR spectroscopic imaging (¹H-MRSI), diffusion-weighted imaging (DWI) and perfusion-weighted imaging (PWI) information at 3 Tesla facilitate such discrimination.

Materials and methods

Twenty-nine patients with histologically verified high-grade gliomas, who had undergone surgical resection and radiotherapy, and had developed new contrast-enhancing lesions close to the treated tumour, underwent MRI, ¹H-MRSI, DWI and PWI at regular time intervals. The metabolite ratios choline (Cho)/normal(_n)Cho_n, N-acetylaspartate (NAA)/NAA_n, creatine (Cr)/Cr_n, lactate/lipids (LL)/LL_n, Cho/Cr_n, NAA/Cr_n, Cho/NAA, NAA/Cr and Cho/Cr were derived from ¹H-MRSI; the apparent diffusion coefficient (ADC) from DWI; and the relative cerebral blood volume (rCBV) from PWI.

Results

In serial MRI, recurrent gliomas showed a progressive enlargement, and radiation injuries showed regression or no modification. Discriminant analysis showed that discrimination accuracy was 79.3 % when considering only the metabolite ratios (predictor, Cho/Cr_n), 86.2 % when considering ratios and ADC (predictors, Cho/Cr_n and ADC), 89.7 % when considering ratios and rCBV (predictors, Cho/Cr_n, Cho/Cr and rCBV), and 96.6 % when considering ratios, ADC and rCBV (predictors, Cho/Cho_n, ADC and rCBV).

Conclusions

The multiparametric 3-T MR assessment based on ¹H-MRSI, DWI and PWI in addition to MRI is a useful tool to discriminate tumour recurrence/progression from radiation effects.

Siu A, Wind JJ, Iorgulescu JB et al (2012) Radiation necrosis following treatment of high grade glioma: a review of the literature and current understanding. Acta Neurochir 154:191–201PubMedCrossRef

Alexiou GA, Tsiouris S, Kyritsis AP et al (2009) Glioma recurrence versus radiation necrosis: accuracy of current imaging modalities. J Neurooncol 95:1–11PubMedCrossRef

McPherson CM, Warnick RE (2004) Results of contemporary surgical management of radiation necrosis using frameless stereotaxis and intraoperative magnetic resonance imaging. J Neurooncol 68:41–47PubMedCrossRef

Scarabino T, Popolizio T, Trojsi F et al (2009) Role of advanced MR imaging modalities in diagnosing cerebral gliomas. Radiol Med 114:448–460PubMedCrossRef

Jain R, Narang J, Sundgren PM et al (2010) Treatment induced necrosis versus recurrent/progressing brain tumor: going beyond the boundaries of conventional morphologic imaging. J Neurooncol 100:17–29PubMedCrossRef

Fink JR, Carr RB, Matsusue E et al (2012) Comparison of 3 Tesla proton MR spectroscopy, MR perfusion and MR diffusion for distinguishing glioma recurrence from post treatment effects. J Magn Reson Imaging 35:56–63PubMedCrossRef

Hu X, Wong KK, Young GS et al (2011) Support vector machine multiparametric MRI identification of pseudoprogression from tumor recurrence in patients with resected glioblastoma. J Magn Reson Imaging 33:296–305PubMedCentralPubMedCrossRef

Matsusue E, Fink JR, Rockhill JK et al (2010) Distinction between glioma progression and post-radiation change by combined physiologic MR imaging. Neuroradiology 52:297–306PubMedCrossRef

Bobek-Billewicz B, Stasik-Pres G, Majchrzak H, Zarudzki L (2010) Differentiation between brain tumor recurrence and radiation injury using perfusion, diffusion-weighted imaging and MR spectroscopy. Folia Neuropathol 48:81–92PubMed

10.

Zeng QS, Li CF, Liu H et al (2007) Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging. Int J Radiat Oncol Biol Phys 68:151–158PubMedCrossRef

11.

Rock JP, Scarpace L, Hearshen D et al (2004) Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and image-guided histopathology with special attention to radiation necrosis. Neurosurgery 54:1111–1117PubMedCrossRef

12.

Henry RG, Vigneron DB, Fischbein NJ et al (2000) Comparison of relative cerebral blood volume and proton spectroscopy in patients with treated gliomas. AJNR Am J Neuroradiol 21:357–366PubMed

13.

Di Costanzo A, Trojsi F, Tosetti M et al (2007) Proton MR spectroscopy of the brain at 3 T: an update. Eur Radiol 17:1651–1662PubMedCrossRef

14.

Scarabino T, Giannatempo GM, Popolizio T et al (2007) 3.0-T functional brain imaging: a 5-year experience. Radiol Med 112:97–112PubMedCrossRef

15.

Di Costanzo A, Pollice S, Trojsi F et al (2008) Role of perfusion-weighted imaging at 3 Tesla in the assessment of malignancy of cerebral gliomas. Radiol Med 113:134–143PubMedCrossRef

16.

Elias AE, Carlos RC, Smith EA et al (2011) MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury. Acad Radiol 18:1101–1108PubMedCrossRef

17.

Smith EA, Carlos RC, Junck LR et al (2009) Developing a clinical decision model: MR spectroscopy to differentiate between recurrent tumor and radiation change in patients with new contrast-enhancing lesions. AJR Am J Roentgenol 192:45–52CrossRef

18.

Zeng QS, Li CF, Zhang K et al (2007) Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury. J Neurooncol 84:63–69PubMedCrossRef

19.

Rabinov JD, Lee PL, Barker FG et al (2002) In vivo 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation effects: initial experience. Radiology 225:871–879PubMedCrossRef

20.

Rock JP, Hearshen D, Scarpace L et al (2002) Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis. Neurosurgery 51:912–919PubMed

21.

Chong VF, Rumpel H, Fan YF, Mukherji SK (2001) Temporal lobe changes following radiation therapy: imaging and proton MR spectroscopic findings. Eur Radiol 11:317–324PubMedCrossRef

22.

Dowling C, Bollen AW, Noworolski SM et al (2001) Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. AJNR Am J Neuroradiol 22:604–612PubMed

23.

Graves EE, Nelson SJ, Vigneron DB et al (2001) Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery. AJNR Am J Neuroradiol 22:613–624PubMed

24.

Kimura T, Sako K, Gotoh T et al (2001) In vivo single-voxel proton MR spectroscopy in brain lesions with ring-like enhancement. NMR Biomed 14:339–349PubMedCrossRef

25.

Movsas B, Li BS, Babb JS et al (2001) Quantifying radiation therapy-induced brain injury with whole-brain proton MR spectroscopy: initial observations. Radiology 221:327–331PubMedCrossRef

26.

Schlemmer HP, Bachert P, Herfarth KK et al (2001) Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy. AJNR Am J Neuroradiol 22:1316–1324PubMed

27.

Taylor JS, Langston JW, Reddick WE et al (1996) Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis. Int J Radiat Oncol Biol Phys 36:1251–1261PubMedCrossRef

28.

Usenius T, Usenius JP, Tenhunen M et al (1995) Radiation-induced changes in human brain metabolites as studied by 1H nuclear magnetic resonance spectroscopy in vivo. Int J Radiat Oncol Biol Phys 33:719–724PubMedCrossRef

29.

Xu JL, Li YL, Lian JM et al (2010) Distinction between postoperative recurrent glioma and radiation injury using MR diffusion tensor imaging. Neuroradiology 52:1193–1199PubMedCrossRef

30.

Hein PA, Eskey CJ, Dunn JF, Hug EB (2004) Diffusion-weighted imaging in the follow-up of treated high-grade gliomas: tumor recurrence versus radiation injury. AJNR Am J Neuroradiol 25:201–209PubMed

31.

Sundgren PC, Fan X, Weybright P et al (2006) Differentiation of recurrent brain tumor versus radiation injury using diffusion tensor imaging in patients with new contrast-enhancing lesions. Magn Reson Imaging 24:1131–1142PubMedCrossRef

32.

Asao C, Korogi Y, Kitajima M et al (2005) Diffusion-weighted imaging of radiation-induced brain injury for differentiation from tumor recurrence. AJNR Am J Neuroradiol 26:1455–1460PubMed

33.

Fatterpekar GM, Galheigo D, Narayana A et al (2012) Treatment-related change versus tumor recurrence in high-grade gliomas: a diagnostic conundrum: use of dynamic susceptibility contrast-enhanced (DSC) perfusion MRI. AJR Am J Roentgenol 198:19–26PubMedCrossRef

34.

Romano A, Rossi Espagnet MC, Calabria LFA et al (2012) Clinical applications of dynamic susceptibility contrast perfusion-weighted MR imaging in brain tumours. Radiol Med 117:445–460PubMedCrossRef

35.

Xu JL, Shi DP, Dou SW et al (2011) Distinction between postoperative recurrent glioma and delayed radiation injury using MR perfusion weighted imaging. J Med Imaging Radiat Oncol 55:587–594PubMedCrossRef

36.

Sugahara T, Korogi Y, Tomiguchi S et al (2000) Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from non neoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol 21:901–909PubMed

37.

Hu LS, Baxter LC, Smith KA et al (2009) Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements. AJNR Am J Neuroradiol 30:552–558PubMedCrossRef

38.

Zheng S, Chheda MG, Verhaak RG (2012) Studying a complex tumor: potential and pitfalls. Cancer J 18:107–114PubMedCentralPubMedCrossRef

39.

Perry A, Schmidt RE (2006) Cancer therapy-associated CNS neuropathology: an update and review of the literature. Acta Neuropathol 111:197–212PubMedCrossRef

40.

Di Costanzo A, ScarabinoT Trojsi F et al (2008) Proton MR spectroscopy of cerebral gliomas at 3 T: spatial heterogeneity, and tumour grade and extent. Eur Radiol 18:1727–1735PubMedCrossRef

41.

Di Costanzo A, Scarabino T, Trojsi F et al (2006) Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancy. Neuroradiology 48:622–631PubMedCrossRef

Titel: Recurrent glioblastoma multiforme versus radiation injury: a multiparametric 3-T MR approach
verfasst von: Alfonso Di Costanzo
Tommaso Scarabino
Francesca Trojsi
Teresa Popolizio
Simona Bonavita
Mario de Cristofaro
Renata Conforti
Adriana Cristofano
Claudio Colonnese
Ugo Salvolini
Gioacchino Tedeschi
Publikationsdatum: 01.08.2014
Verlag: Springer Milan
Erschienen in: La radiologia medica / Ausgabe 8/2014
Print ISSN: 0033-8362
Elektronische ISSN: 1826-6983
DOI: https://doi.org/10.1007/s11547-013-0371-y

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Recurrent glioblastoma multiforme versus radiation injury: a multiparametric 3-T MR approach